Research Article
Volume 3 Issue 8 - 2020
Integrated Approaches for Reversing the Progression of Type-2 Diabetes in Advanced Diabetic and Prediabetic Individuals
Roopa Lakshmi1, Rama Mishra2, Shashi Kumar2, Kaveri Kuttappa2, Nivedita2, Deepika2 and Gundu HR Rao3*
1Founder, Director, Wellbeeing, Multi-speciality and Integrated Health Centre (IHC), India
2Staff Physicians and Researchers at IHC, India
3Emeritus Professor, Laboratory Medicine and Pathology, University of Minnesota, USA and Founder CEO, Institute for Integrative Medicine (IIM), India
*Corresponding Author: Gundu HR Rao, Emeritus Professor, Laboratory Medicine and Pathology, University of Minnesota, USA and Founder CEO, Institute for Integrative Medicine (IIM), India.
Received: June 11, 2020; Published: July 31, 2020




Abstract

Metabolic diseases have rapidly progressed to epidemic proportions worldwide. In the last four decades, obesity has increased by four-fold and type-2 diabetes by two-fold. Vascular diseases (VDs) have remained the number one killer and have retained this status for over a century. Despite some decline in the morbidity and premature mortality related to VDs, in industrialized nations, these diseases have not been under control worldwide, and we see no hopes of reducing, reversing or preventing metabolic diseases in the near future. Modern medicine has failed to address the prevention of these chronic diseases. Even though it is assumed that modern medicine has wiped out the infectious diseases, occasional pandemics (current Corona Virus Pandemic) demonstrates, how ill prepared we are, when it comes to containment or prevention of diseases. According to a Centre for Disease Control (CDC), USA, more than 700,000 people contract infection in the so-called modern hospitals of the USA in a given year and 70,000 die of such hospital acquired infections. There is an increasing interest in the development of Integrative Medicine, to address the need to reduce, reverse, or prevent the increase in the incidence and prevalence of metabolic diseases. In a preliminary study at the Institute for Integrative Therapies, Bengaluru, India, we subjected known diabetic individuals to a structured diabetes prevention protocol, which included complementary therapies, such as Naturopathy, Ayurveda, Yoga and Allopathy. In this retrospective study, although original cohort had more than three hundred subjects, we selected 56 subjects, for whom we had complete data for presentation in this report. Of the 56 individuals followed with Diabetes Reversal Protocol, 21.4% discontinued medication within 100 days, 50% reduced the medication needed to maintain the HbA1c within 90 days. Whereas 18% reduced medication after 140 days and 10% attained lower HbA1c levels with medication. We have designed future studies, to explore the mechanisms by which one or more of the individual components of this intervention protocol, influences the metabolic risks related to this disease, by using an array of non-invasive diagnostic tools, such as Abbott Free Style Libre-14 day, ambulatory glucose monitor (AMG), LD-diagnostic tools for monitoring a variety of metabolic risks as well as wellness index. We strongly believe that traditional medicine approach of developing complementary therapies, will be a ‘game changer’ in the way future preventive medicine will be delivered.

Keywords: Ambulatory Glucose Monitor (AMG); Type-2 Diabetes (T2D); Vascular Diseases (VDs)

References

  1. Rao GHR and Kakkar VV. “Coronary Artery Disease in South Asians: Epidemiology, Risk Factors, and Prevention”. JP Medical Publishers, New Delhi, India (2001).
  2. NCD Risk Factor Collaboration (NCD-RisC). “Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants”. Lancet 389 (2017): P37-P55.
  3. Global Burden of Metabolic Risk Factors for Chronic Disease Collaboration. “Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment”. The Lancet Diabetes and Endocrinology 2 (2014): 634-647.
  4. NCD Risk Factor Collaboration. “Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants”. Lancet 387 (2016): 1513-1530.
  5. Kearney PM., et al. “Global burden of hypertension: analysis of worldwide data”. Lancet 365 (2005): 217-223.
  6. Evans A., et al. “Trends in coronary artery disease risk factors in the WHO MONICA project”. International Journal of Epidemiology 30 (2001): S35-S40.
  7. Juonala M., et al. “The 21-year follow up of the cardiovascular risk in young Finns Study: risk factor levels, secular trends and east-west difference”. Journal of Internal Medicine 255 (2004): 457-468.
  8. Reilly JJ., et al. “Determining the worldwide prevalence of obesity”. Lancet 391 (2018): 1773-1774.
  9. NCD Risk Factor Collaboration (NCD-RisC). “Worldwide trends in body mass-index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults”. Lancet 390 (2017): 2627-2642.
  10. NCD Risk Factor Collaboration (NCD-RisC). “Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1968 population-based measurement studies with 19.2 million participants”. Lancet 387 (2016): 1377-1396.
  11. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediate Effects). “Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary artery disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants”. Lancet 383 (2014): 970-983.
  12. WHO. “Global action plan for the prevention and control of non-communicable diseases 2013-2020? World Health Organization, Geneva, Switzerland (2013).
  13. Kontis V., et al. “Contribution of six risk factors to achieving the 25 x25 non-communicable disease mortality reduction target: a modeling study”. Lancet 384 (2014): 427-437.
  14. Ng M., et al. “Global, regional and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013”. Lancet 384 (2014): 766-781.
  15. NCD Risk Factor Collaboration (NCD-RisC). “Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants”. Lancet 387 (2016): 1513-1530.
  16. Seuring T., et al. “The economic costs of type-2 diabetes: a global systematic review”. Pharmacoeconomics 33 (2015): 811-831.
  17. Danaei G., et al. “National, regional, and global trends in fasting glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants”. Lancet 378 (2011): 31-40.
  18. Beagley J., et al. “Global estimates of undiagnosed diabetes in adults”. Diabetes Research and Clinical Practice 103 (2014): 150-160.
  19. Gakidou E., et al. “Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health surveys”. Bulletin of the World Health Organization 89 (2011): 172-183.
  20. Shen X., et al. “The diabetes epidemic in China: An integrated review of national surveys”. Endocrine Practice 22.9 (2016): 1119-1129. 
  21. Yip WCY., et al. “Prevalence of Prediabetes across ethnicities: A review of Impaired Fasting Glucose (IFG) and Impaired Glucose tolerance (IGT) for classification of Dysglycemia”. Nutrients 9 (2017): 1273.
  22. Song SH and Hardisty CA. “Early-onset type- diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk”. Expert Review of Cardiovascular Therapy 6.3 (2014): 315-322.
  23. Krueger A., et al. “Dietary and Lifestyle changes reverses hypertension rapidly”. Current Developments in Nutrition 3.1 (2019): 16-20. 
  24. Kumayika SK., et al. “Population-based Prevention of Obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance: A scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary committee for Prevention ( Formerly the Expert Panel on Population and Prevention Science)”. CUTS Institute for Regulation and Competition 118 (2008): 428-464.
  25. Taylor R., et al. “Understanding the mechanism of reversal of type-2 diabetes. Personal View”. The Lancet Diabetes and Endocrinology 7.9 (2019): 726-736.
  26. Di Cesare M., et al. “The Contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries”. International Journal of Epidemiology 42.3 (2013): 838-848.
  27. Raghuram N., et al. “A Yoga based lifestyle for type-2 diabetes: need for a nation-wide movement to control type 2 diabetes”. Journal of Diabetes Research 5.5 (2018): 188-193.
  28. McDermott KA., et al. “A yoga intervention for type-2 diabetes risk reduction: a pilot randomized controlled trial”. BMC Complementary and Alternative Medicine 14 (2014): 212. 
  29. Nagarathna R., et al. “Efficacy of yoga life style modification program on medication score and lipid profile in type-2 diabetes- a randomized control study”. International Journal of Diabetes in Developing 33.3 (2012):122-130.
  30. Singh AK., et al. “Partitioning of radiological , stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol”. Diabetes, Metabolic Syndrome Clinical Research Revenue 13 (2019): 2705-2713.
  31. Covington MB. “Traditional Chinese Medicine in the Treatment of Diabetes”. Diabetes Spectrum 14.3 (2001):154-159.
  32. Chimodke SM., et al. “Effect of Yoga on Blood Glucose Levels in Patients with Type 2 Diabetes Mellitus”. Journal of Clinical and Diagnostic Research 9.4 (2015): CC01-CC03. 
  33. Aljasir B., et al. “Yoga Practice for the Management of Type II Diabetes Mellitus in Adults: A systematic review”. Evidence-Based Complementary and Alternative Medicine 7.4 (2010): 399-408.
  34. Cui J., et al. “Effects of yoga in adults with type-2 diabetes mellitus: A meta-analysis”. Journal of Diabetes Investigation 8.2 (2017): 201-209.
  35. Ramamoorthi R., et al. “The effect of yoga practice on glycemic control and other health parameters in the prediabetic state: A systematic review and meta-analysis”. PLoS One 14.10 (2019): e0221067.
  36. Gandhi PG and Rao GHR. “The Spectral Analysis of Photoplethysmography to Evaluate an Independent Cardiovascular Risk Factor”. International Journal of General Medicine 7 (2014): 39-47.
  37. Gandhi PG Rao. “Detection of Neuropathy Using SudoMotor Tests in Type-2 Diabetes”. Degenerative Neurological and Neuromuscular Diseases 5 (2015): 1-7.
  38. Maarek A., et al. “Identifying autonomic neuropathy and endothelial dysfunction in Type 11 diabetic patients”. EC Neurology 22 (2015): 63-78.
  39. Rao GHR and Gandhi PG. “Need for a non-invasive diagnostic platform for early detection and management of cardiometabolic disorders”. European Journal of Preventive Cardiology 3.3 (2014): 93-98.
  40. Obi Uzomba and Rao GHR. “Management of diabetes, metabolic syndrome and cardiovascular complications using a novel diagnostic platform”. Interventions in Obesity and Diabetes 2.3 (2018). 
  41. Singh S., et al. “Influence of pranayamas and yoga‐asanas on serum insulin, blood glucose and lipid profile in type 2 diabetes”. Indian Journal of Clinical Biochemistry 23 (2008): 365-368. 
  42. Kyizom T., et al. “Effect of pranayama and yoga‐asana on cognitive brain functions in type 2 diabetes‐P3 event related evoked potential (ERP)”. Indian Journal of Medical Research 131 (2010): 636-640. 
  43. Popli U., et al. “Research letter‐the role of yoga as a lifestyle modification in treatment of diabetes mellitus: results of a pilot study”. Alternative Therapies in Health and Medicine 20 (2014): 24-26. 
  44. Jyotsna VP., et al. “Completion report: Effect of Comprehensive Yogic Breathing program on type 2 diabetes: A randomized control trial”. Indian Journal of Endocrinology and Metabolism 18 (2014): 582–584. 
  45. Skoro‐Kondza L., et al. “Community based yoga classes for type 2 diabetes: an exploratory randomized controlled trial”. BMC Health Services Research 9 (2009): 33. 
  46. Shantakumari N., et al. “Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia”. Indian Heart Journal 65 (2003): 127-131. 
  47. Sridharan K., et al. “Ayurvedic treatments for diabetes mellitus”. The Cochrane Database of Systematic Reviews
  48. Khera AV., et al. “Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease”. The New England Journal of Medicine 375 (2016): 2349-2358.
  49. Gregory JW. “Prevention of Obesity and Metabolic Syndrome in Children”. Frontiers in Endocrinology (2019). 
  50. Di Cesare M., et al. “The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action”. BMC Medicine 17.212 (2019).
  51. Malmefeldt E and Rao GHR. “Changing concepts of healthcare: Physical activity, Fitness and Wellness. EC Endocrinol”. Metabolism Research 4.6 (2019): 238-250.
  52. Malmefeldt E and Rao GHR. “Non-invasive Diagnostic Tools: Cardiometabolic Risk Assessment and Prediction”. Journal of Clinical Cardiology and Diagnostics 2.1 (2019): 1-10.
Citation: Gundu HR Rao., et al. “Integrated Approaches for Reversing the Progression of Type-2 Diabetes in Advanced Diabetic and Prediabetic Individuals”. EC Clinical and Medical Case Reports 3.8 (2020): 107-119.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk